Several Medicine by Design-funded investigators were named Canada Research Chairs, and two received New Frontiers in Research Fund (NFRF) Transformation stream grants.
Funding gives cutting-edge regenerative medicine concepts impacting heart disease, lung transplantation, degenerative brain disease and end-stage liver disease a pathway to clinical translation.
Can we make lung transplants a thing of the past?
Medicine by Design is expanding its regenerative medicine research portfolio with the addition of four multi-disciplinary, multi-institution projects. “These team projects build on Medicine by Design’s successes over its first three years and will strengthen the University of Toronto and its affiliated hospitals as a global centre for regenerative medicine,” said Michael Sefton, executive director of Medicine by Design.
